Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) EBT Margin (2024)

Historic EBT Margin for Zentalis Pharmaceuticals (ZNTL) over the last 1 years, with Q4 2024 value amounting to 177.47%.

  • Zentalis Pharmaceuticals' EBT Margin changed N/A to 177.47% in Q4 2024 from the same period last year, while for Sep 2025 it was 556.56%, marking a year-over-year decrease of 1150300.0%. This contributed to the annual value of 245.74% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported EBT Margin of 177.47% as of Q4 2024.
  • In the past 5 years, Zentalis Pharmaceuticals' EBT Margin ranged from a high of 25.11% in Q1 2024 and a low of 177.47% during Q4 2024